A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
This bill directs the U.S. Postal Service to issue and sell an Alzheimer's Disease Research Semipostal Stamp.
Proceeds from the sale of the stamp must be transferred to the National Institutes of Health for medical research relating to Alzheimer's disease.
The stamp must be made available to the public for six years.
Any limitation relating to whether more than one semipostal stamp may be offered for sale at the same time shall not apply to the stamp issued under this bill.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2208: A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.. 115th Congress. Open America. https://openamerica.io/bill/115-S-2208/
"S. 2208: A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2208/.
S. 2208, 115th Cong. (2026), https://openamerica.io/bill/115-S-2208/.
[S. 2208: A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.](https://openamerica.io/bill/115-S-2208/)